Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for ...
Mainz Biomed NV trading halted, news pending
NV trading halted, news pendingDon't Miss our Black Friday Offers:Unlock your investing potential with TipRanks ...
Mainz BioMed NV: Mainz Biomed Announces Stock Split
Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...
Investing2d
Mainz Biomed-Aktie erreicht 52-Wochen-Tief bei 0,18 US-Dollar
In einem turbulenten Marktumfeld ist die Aktie von Mainz Biomed (NASDAQ: MYNZ) BV auf ein 52-Wochen-Tief von 0,18 US-Dollar gefallen. Dieser deutliche Rückgang spiegelt eine drastische Veränderung im ...
Benzinga Finance on MSN4d
Mainz Biomed $MYNZ & Thermo Fisher Partner On Next-Gen Colorectal Cancer Screening Product
Mines Biomed, a molecular genetics diagnostic company, has entered into a collaborative agreement with Thermo Fisher ...
EQS-News: Mainz Biomed Announces Stock Split
Mainz Biomed Announces Stock Split. BERKELEY, US and MAINZ, Germany – November 29, 2024 - Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular ...
sharewise5d
EQS-News: Mainz Biomed gibt Aktienzusammenlegung bekannt
Emittent / Herausgeber: Mainz BioMed N.V. / Schlagwort (e): Sonstiges Mainz Biomed gibt Aktienzusammenlegung bekannt 29.11 ...
Mainz Biomed Announces Stock Split
Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in ...